Tag: Richard A. Van Etten

  • Nation & World

    Resistance mutation found for Gleevec

    The drug Gleevec was stunningly successful in treating patients with chronic myelogenous leukemia (CML) at early stages of disease, but quickly stopped working in most patients with more advanced forms…

    1 minute